Ladas, E. J., Sheng, H., Athale, U. H., Asselin, B. L., Clavell, L. A., Cole, P. D., Flamand, Y., Leclerc, J.-M., Laverdiere, C., Michon, B., Sallan, S. E., Silverman, L. B., Welch, J. J. G., Yao, S., & Kelly, K. M. (2025). Overweight or Obesity and Outcomes in Children With Acute Lymphoblastic Leukemia. JAMA Network Open, 8(5), e259952. https://doi.org/10.1001/jamanetworkopen.2025.9952

Winestone, L. E., Yang, J., Banerjee, T., Sangaramoorthy, M., Kahn, J., Abrahão, R., Keegan, T. H., Cheng, I., Gomez, S. L., & Shariff‐Marco, S. (2025). Impact of neighborhood archetypes on overall mortality among young patients with acute leukemia in California. Cancer, 131(9). Portico. https://doi.org/10.1002/cncr.35863

Hughes, T. M., Shrivastava, N., Silverman, L. B., Frazier, A. L., Gupta, S., & Denburg, A. (2025). Forecasting Asparaginase Need and Cost for Childhood Cancer Using ACCESS FORxECAST. JCO Global Oncology, 11. https://doi.org/10.1200/go-24-00444

Pelland-Marcotte, M.-C., Belaktib, A., Droit, A., Remy, M. M., Clement, J. G., Bianco, S., Ma, Y., Liu, J., Herrmann, L., Raufaste-Cazavieille, V., Joly-Beauparlant, C., Mangnier, L., Leclercq, M., Sontag, T., Caron, M., St-Onge, P., Langlois, S., Koch, V., Flamand, Y., … Santiago, R. (2024). Molecular signatures associated with venous thromboembolism in children with acute lymphoblastic leukemia. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.12.007

Jones, R. R., Madrigal, J. M., Troisi, R., Surcel, H.-M., Öhman, H., Kivelä, J., Kiviranta, H., Rantakokko, P., Koponen, J., Medgyesi, D. N., McGlynn, K. A., Sampson, J., Albert, P. S., & Ward, M. H. (2023). Maternal serum concentrations of per- and polyfluoroalkyl substances and childhood acute lymphoblastic leukemia. JNCI: Journal of the National Cancer Institute, 116(5), 728–736. https://doi.org/10.1093/jnci/djad261

Paolino, J., Dimitrov, B., Apsel Winger, B., Sandoval-Perez, A., Rangarajan, A. V., Ocasio-Martinez, N., Tsai, H. K., Li, Y., Robichaud, A. L., Khalid, D., Hatton, C., Gillani, R., Polonen, P., Dilig, A., Gotti, G., Kavanagh, J., Adhav, A. A., Gow, S., Tsai, J., … Pikman, Y. (2023). Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma. Clinical Cancer Research, 29(22), 4613–4626. https://doi.org/10.1158/1078-0432.ccr-22-2562

Baruchel, A., Bourquin, J.-P., Crispino, J., Cuartero, S., Hasle, H., Hitzler, J., Klusmann, J.-H., Izraeli, S., Lane, A. A., Malinge, S., Rabin, K. R., Roberts, I., Ryeom, S., Tasian, S. K., & Wagenblast, E. (2023). Down syndrome and leukemia: from basic mechanisms to clinical advances. Haematologica, 108(10), 2570–2581. https://doi.org/10.3324/haematol.2023.283225

Foti, A., Stein, D., Seidel, D., Levine, J., Hijiya, N., Williams, O., George, D., Bhatia, M., & Satwani, P. (2023). Clofarabine for Lymphodepletion Before CAR-T-Cell Infusion: A Brief Case Report. Journal of Pediatric Hematology/Oncology, 45(4), e551–e554. https://doi.org/10.1097/mph.0000000000002668

Blanco-Lopez, J., Iguacel, I., Pisanu, S., Almeida, C., Steliarova-Foucher, E., Sierens, C., Gunter, M., Ladas, E., Barr, R., Van Herck, K., & Huybrechts, I. (2023). Role of Maternal Diet in the Risk of Childhood Acute Leukemia: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health, 20(7), 5428. https://doi.org/10.3390/ijerph20075428

Tsai, C.-Y., Saito, T., Sarangdhar, M., Abu-El-Haija, M., Wen, L., Lee, B., Yu, M., Lipata, D. A., Manohar, M., Barakat, M. T., Contrepois, K., Tran, T. H., Theoret, Y., Bo, N., Ding, Y., Stevenson, K., Ladas, E. J., Silverman, L. B., Quadro, L., … Husain, S. Z. (2023). A systems approach points to a therapeutic role for retinoids in asparaginase-associated pancreatitis. Science Translational Medicine, 15(687). https://doi.org/10.1126/scitranslmed.abn2110

Wayne, A. S., Huynh, V., Hijiya, N., Rouce, R. H., Brown, P. A., Krueger, J., Kitko, C. L., Ziga, E. D., Hermiston, M. L., Richards, M. K., Baruchel, A., Schuberth, P. C., Rossi, J., Zhou, L., Goyal, L., Jain, R., Vezan, R., Masouleh, B. K., & Lee, D. W. (2022). Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia. Haematologica, 108(3), 747–760. https://doi.org/10.3324/haematol.2022.280678

Park, H., Uhlemann, A. C., Jacobs, S. S., Mowbray, C., Jubelirer, T., Kelly, K. M., Walters, M., & Ladas, E. J. (2023). Title: Obesogenic microbial signatures and the development of obesity in childhood acute lymphoblastic leukemia. Leukemia Research, 126, 107017. https://doi.org/10.1016/j.leukres.2023.107017

Stefanski, H. E., Eaton, A., Baggott, C., Rossoff, J., Verneris, M. R., Prabhu, S., Pacenta, H. L., Phillips, C. L., Talano, J.-A., Moskop, A., Margossian, S. P., Myers, G. D., Karras, N. A., Brown, P. A., Qayed, M., Hermiston, M., Satwani, P., Krupski, M. C., Keating, A. K., … Schultz, L. M. (2023). Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium. Blood Advances, 7(4), 541–548. https://doi.org/10.1182/bloodadvances.2022007246

Kahn, J. M., Stevenson, K., Beauchemin, M., Koch, V. B., Cole, P. D., Welch, J. J. G., Gage-Bouchard, E., Karsenty, C., Silverman, L. B., Kelly, K. M., & Bona, K. (2022). Oral Mercaptopurine Adherence in Pediatric Acute Lymphoblastic Leukemia: A Survey Study From the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium. Journal of Pediatric Hematology/Oncology Nursing, 40(1), 17–23. https://doi.org/10.1177/27527530221122685

Beauchemin, M., Santacroce, S. J., Bona, K., Dang, H., Alexander, S., Allen, K., De Los Santos, C., Fisher, B., Muñeton-Castaño, Y., Ponce, O., Vargas, S., Sugalski, A., Sung, L., & Parsons, S. (2022). Rationale and design of Children’s Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States. BMC Health Services Research, 22(1). https://doi.org/10.1186/s12913-022-08201-0

Reglero, C., Dieck, C. L., Zask, A., Forouhar, F., Laurent, A. P., Lin, W.-H. W., Albero, R., Miller, H. I., Ma, C., Gastier-Foster, J. M., Loh, M. L., Tong, L., Stockwell, B. R., Palomero, T., & Ferrando, A. A. (2022). Pharmacologic Inhibition of NT5C2 Reverses Genetic and Nongenetic Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia. Cancer Discovery, 12(11), 2646–2665. https://doi.org/10.1158/2159-8290.cd-22-0010

Mahajan, R. G., Moisander Joyce, H., Green, N., Hijiya, N., & Jain, N. G. (2022). Rare Presentation of Atypical Hemolytic Uremic Syndrome in a Child With Acute Lymphocytic Leukemia and Pancreatitis. Journal of Pediatric Hematology/Oncology, 44(7), 412–414. https://doi.org/10.1097/mph.0000000000002409

Moskop, A., Pommert, L., Baggott, C., Prabhu, S., Pacenta, H. L., Phillips, C. L., Rossoff, J., Stefanski, H. E., Talano, J.-A., Margossian, S. P., Verneris, M. R., Myers, G. D., Karras, N. A., Brown, P. A., Qayed, M., Hermiston, M. L., Satwani, P., Krupski, C., Keating, A. K., … Schultz, L. M. (2022). Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia. Blood Advances, 6(14), 4251–4255. https://doi.org/10.1182/bloodadvances.2021006393

Schultz, L. M., Baggott, C., Prabhu, S., Pacenta, H. L., Phillips, C. L., Rossoff, J., Stefanski, H. E., Talano, J.-A., Moskop, A., Margossian, S. P., Verneris, M. R., Myers, G. D., Karras, N. A., Brown, P. A., Qayed, M., Hermiston, M., Satwani, P., Krupski, C., Keating, A. K., … Laetsch, T. W. (2022). Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report. Journal of Clinical Oncology, 40(9), 945–955. https://doi.org/10.1200/jco.20.03585

Tran, T. H., Langlois, S., Meloche, C., Caron, M., Saint-Onge, P., Rouette, A., Bataille, A. R., Jimenez-Cortes, C., Sontag, T., Bittencourt, H., Laverdière, C., Lavallée, V.-P., Leclerc, J.-M., Cole, P. D., Gennarini, L. M., Kahn, J. M., Kelly, K. M., Michon, B., Santiago, R., … Sinnett, D. (2022). Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001. Blood Advances, 6(4), 1329–1341. https://doi.org/10.1182/bloodadvances.2021005634

Fabrizio, V. A., Phillips, C. L., Lane, A., Baggott, C., Prabhu, S., Egeler, E., Mavroukakis, S., Pacenta, H., Rossoff, J., Stefanski, H. E., Talano, J.-A., Moskop, A., Margossian, S. P., Verneris, M. R., Myers, G. D., Karras, N. A., Brown, P. A., Qayed, M., Hermiston, M., … Schultz, L. M. (2022). Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report. Blood Advances, 6(2), 600–610. https://doi.org/10.1182/bloodadvances.2021005564

Unger, J. M., Beauchemin, M., & Hershman, D. L. (2021). Adolescent and young adult enrollment to a National Cancer Institute–sponsored National Clinical Trials Network Research Group over 25 years. Cancer, 127(24), 4574–4584. Portico. https://doi.org/10.1002/cncr.33855